Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02984891 · ClinicalTrials.gov registry record

Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging

A clinical trial, sponsored by Columbia University.

Terminated
Registry status
7
Enrollment target

NCT02984891: Clinical Trial study, sponsored by Columbia University.

NCT02984891 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02984891 was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
7 participants
Enrollment target

Study Summary

Both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are standardly used and have been extensively studied separately to guide percutaneous coronary intervention and improve long-term outcomes. In this study, the investigators aim to directly compare high-definition IVUS images to OCT in the same patients to determine the differences between each modality as they relate to imaging coronary pathology, with the goal of determining which modality is most appropriate in particular clinical scenarios.

Interventions

  • PROCEDURE Optical Coherence Tomography (OCT)
  • PROCEDURE Intravascular Ultrasound (IVUS)

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2016-10-06
Est. Completion 2018-06-27
Columbia University

958 total trials

Why NCT02984891 stopped before completion

NCT02984891 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Optical Coherence Tomography (OCT) is the first listed.

NCT02984891 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02984891 about?

NCT02984891 is a clinical study titled "Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging". Both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are standardly used and have been extensively studied separately to guide percutaneous coronary intervention and improve long-term outcomes. In this study, the investigators aim to directly compare high-definition IVUS image...

What is the current status of trial NCT02984891?

This trial is currently terminated. The enrollment target is 7 participants. The study started on 2016-10-06. Estimated completion is 2018-06-27.

What interventions are being tested in trial NCT02984891?

The interventions under investigation include: Optical Coherence Tomography (OCT) (PROCEDURE), Intravascular Ultrasound (IVUS) (PROCEDURE).

Who is sponsoring clinical trial NCT02984891?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02984891, the US trial registry maintained by the National Library of Medicine. NCT02984891 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.